DOI QR코드

DOI QR Code

GBCK25, fermented ginseng, attenuates cardiac dysfunction in high fat diet-induced obese mice

  • Sharmila, Judith (College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Aravinthan, Adithan (College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Shin, Dong Gue (Research Center, GeneralBio Co. Ltd., Jeonbuk Technopark R&D Support Center) ;
  • Seo, Jeong Hun (Research Center, GeneralBio Co. Ltd., Jeonbuk Technopark R&D Support Center) ;
  • Kim, Bumseok (College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Kim, Nam Soo (College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Kang, Chang-Won (College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Kim, Jong-Hoon (College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University)
  • 투고 : 2017.04.24
  • 심사 : 2017.05.12
  • 발행 : 2018.07.15

초록

The fermentation of medicinal herbs facilitated by microbes is assumed to exert promising therapeutic efficacy on the absorption, bioavailability, and pharmacological effects by speeding up the making or conversion of active constituents into their metabolites. We examined the cardioprotective potential of fermented ginseng, GBCK25, against high-fat diet (HFD)-induced metabolic and functional illnesses as following the essential analysis such as electrocardiographic parameters, alterations of body and organ weights, and echocardiographic studies. The results exhibited that body weights were significantly reduced and the gain of different organ weights were partly eased by GBCK25 treatment. Echocardiography results proposed the amelioration of heart function through normalized levels of left ventricle systolic pressure, ejection fraction, and fractional shortening. These outcomes deliver straight confirmation that GBCK25 could be a potential nutraceutical source for the relief of HFD-induced obesity mediated cardiac dysfunctions.

키워드

참고문헌

  1. Kim CM, Yi SJ, Cho IJ, Ku SK. Red-Koji fermented red ginseng ameliorates high fat diet-induced metabolic disorders in mice. Nutrients 2013;5:4316-32. https://doi.org/10.3390/nu5114316
  2. Wong VK, Cheung SS, Li T, Jiang ZH,Wang JR, Dong H, Yi XQ, Zhou H, Liu L. Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-kappaB signaling. J Cell Biochem 2010;111:899-910. https://doi.org/10.1002/jcb.22778
  3. Mollah ML, Kim GS, Moon HK, Chung SK, Cheon YP, Kim JK, Kim KS. Antiobesity effects of wild ginseng (Panax ginseng Meyer) mediated by PPAR-gamma, GLUT4, and LPL in ob/ob mice. Phytother Res 2009;23:220-5. https://doi.org/10.1002/ptr.2593
  4. Karmazyn M, Moey M, Gan XT. Therapeutic potential of ginseng in the management of cardiovascular disorders. Drugs 2011;71:1989-2008. https://doi.org/10.2165/11594300-000000000-00000
  5. Lee DC, Lau AS. Effects of Panax ginseng on tumor necrosis factor-alpha-mediated inflammation: a mini-review. Molecules 2011;16:2802-16. https://doi.org/10.3390/molecules16042802
  6. Kim DH. Metabolism of ginsenosides to bioactive compounds by intestinal microfloraand its industrial application. J Ginseng Res 2009;33:165-76. https://doi.org/10.5142/JGR.2009.33.3.165
  7. Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic, and histoarchitectural evaluation. Eur J Pharmacol 2010;644:160-8. https://doi.org/10.1016/j.ejphar.2010.06.065